Evidence map›Paper›PMID 41991748›Full record

ArticleBreast cancer research and treatment2026

Factors associated with and patterns of alcohol intake in late survivorship for breast cancer survivors.

Sanjna Rajput, Robert A Vierkant, Kayleigh N Olson, Nicole L Larson, Daniela L Stan, Dawn M Mussallem, Stacy D D'Andre, Fergus J Couch, Janet E Olson, Ciara C O'Sullivan and 1 more

Abstract read
In one paragraph

Article in Breast cancer research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sanjna RajputMayo Clinic School of Graduate Medical Education, Internal Medicine Residency, Mayo Clinic, Rochester, MN, USA.
Robert A VierkantDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Kayleigh N OlsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Nicole L LarsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Daniela L StanDepartment of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Dawn M MussallemDepartment of General Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Stacy D D'AndreDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Fergus J CouchDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Janet E OlsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Ciara C O'SullivanDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Kathryn J RuddyDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. ruddy.kathryn@mayo.edu.

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
Resolving the cancer relevance of predisposition gene mutationsR35CA253187 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2020 to 2026
$5.8M
Curation Expert Panels for BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer GenesU24CA258058 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2022 to 2026
$1.3M
NCI NIH HHS Grant Number P30 CA015083NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA116201NCI NIH HHS R35 CA253187NCI NIH HHS R35 CA253187, U24 CA258058 and P50 CA116201NCI NIH HHS U24 CA258058
6 · The paper itself

Abstract

purposeTo evaluate alcohol intake trends and identify demographic, clinical, lifestyle, and socioeconomic factors associated with alcohol consumption in late survivorship among breast cancer survivors.

methodsIndividuals diagnosed with stage 0-3 breast cancer enrolled in the Mayo Clinic Breast Disease registry between 2014 and 2022 reported their average weekly alcohol intake at baseline (time of diagnosis) and at approximately 4 years post-diagnosis. Alcohol intake was divided into four categories, and cross-sectional associations with demographic, clinical, and lifestyle factors were examined using Monte Carlo-based Fisher exact tests and multivariable multinomial logistic regression. Changes in alcohol consumption from baseline to Year 4 were evaluated using Bowker's test of symmetry and multinomial models.

resultsAmong 719 participants, alcohol intake 4 years post-diagnosis closely resembled baseline patterns, with 30.2% of patients reporting no alcohol use and 48.8% of patients consuming 1-4 drinks per week. Younger age and current smoking status were strongly associated with higher intake at Year 4. Exercise and better physical health were associated with higher alcohol intake in univariable models; however, they were not in adjusted models. From time of diagnosis to Year 4, 15.6% of patients decreased their alcohol intake, 10.2% increased their alcohol intake, and 74.3% reported no change. Higher levels of mild-intensity exercise were associated with an elevation in alcohol intake over time.

conclusionAlcohol consumption in late survivorship was similar to that at the time of diagnosis, after an initial decline in this cohort during early survivorship. Younger age and smoking were associated with greater Year 4 alcohol intake.

Indexed as

Alcohol DrinkingBreast NeoplasmsCancer SurvivorsAdultAgedCross-Sectional StudiesFemaleHumansLife StyleMiddle AgedSurvivorshipBreast neoplasmsHealth behaviorSurvivors

Identifiers

PMID41991748
PMCPMC13086789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.